-
Breaking News: FDA approves Opsynvi as 1st single-tablet PAH combo treatment
Late Friday, we had some exciting news: the FDA approved a new combo treatment for PH. It’s the first single-tablet combo treatment. This fixed-dose tablet contains a combination of macitentan and tadalafil — to be marketed under the brand name Opsynvi — to treat adults with pulmonary arterial hypertension (PAH).
You can read our PH News team’s full story by clicking the link below.
FDA approves Opsynvi as 1st single-tablet PAH combo treatmentHave you heard of this new treatment before? Where and what are your thoughts on this exciting new treatment?
Log in to reply.